Purchase Order 75F40123P00030
Award Date 1/29/23
Potential Completion Date 12/30/27
Potential Value $423K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Food and Drug Administration awarded a firm fixed-price purchase order to Illumina, Inc. for an annual maintenance agreement covering seven Illumina sequencing instruments, with a base year and four option years. The contract has a ceiling value of $817,521.04 and extends through March 23, 2029, with performance to be conducted in Laurel, Maryland. This maintenance agreement provides preventive maintenance, calibration, and repair services essential to keeping FDA's genomic sequencing...
- The Food and Drug Administration awarded a delivery order valued at $124.5K to Illumina, Inc. for preventative maintenance services on a MiSeq benchtop sequencer. This firm fixed-price delivery order, issued on November 12, 2014, with an ultimate completion date of December 5, 2015, represents a critical support service for FDA laboratory operations in San Diego, California. The award carries no set-aside designation, reflecting Illumina's specialized position as the manufacturer of the...
- This is a firm-fixed price purchase order awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies. The contract is for a 12-month preventative maintenance service agreement with four 12-month option periods, to support five MiSeq sequencing instruments for the FDA's Center for Food Safety and Applied Nutrition (CFSAN). The contract has a ceiling value of $425,145.40 and does not utilize a...
- The Food and Drug Administration (FDA) awarded a delivery order to Illumina, Inc. for preventative maintenance services on a MiSeq benchtop sequencer. This firm fixed-price delivery order, valued at $136,950, was awarded on November 18, 2014, with an ultimate completion date of December 5, 2015, and will be performed in San Diego, California. The award carries no set-aside designation, reflecting Illumina's specialized position as the sole viable source for maintenance services on its...
- This is a firm fixed-price delivery order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing technologies. The contract is for $12,450.00 to provide preventative maintenance services for Illumina's MISEQ sequencing system. The contract has an ultimate completion date of June 30, 2018 and does not utilize any set-aside designations. Illumina, headquartered in San Diego, California, is a...
- The Food and Drug Administration (FDA) awarded a $36,497 firm fixed-price delivery order to Illumina, Inc. on March 5, 2014, for preventative maintenance services on a MiSeq benchtop sequencer. The work was performed at Illumina's San Diego, California facility, with an ultimate completion date of September 13, 2017. This delivery order was issued without a set-aside designation, reflecting Illumina's specialized technological position as the manufacturer of the proprietary sequencing...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract is for the service and maintenance of one Illumina MiSeq sequencing system, with a ceiling value of $34,972.40 and a performance period ending on September 24, 2024. Illumina, a for-profit organization and manufacturer of goods, has been awarded numerous prime federal contracts and...
- The Food and Drug Administration (FDA) awarded a purchase order valued at $180,080 to Illumina, Inc. for a preventive maintenance agreement on an Illumina Next Generation Sequencer. The contract was awarded on October 24, 2019, with an ultimate completion date of November 12, 2024, and was performed at the FDA facility in Jefferson, Arkansas. This firm fixed-price contract does not utilize any set-aside designation, reflecting Illumina's specialized capabilities in genomic sequencing...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions. The contract, valued at $89,573.00, is for preventative maintenance and repair services for the agency's MiSeq sequencing system. The contract has an ultimate completion date of April 30, 2028 and does not include any set-aside designation. Illumina has previously provided a range of sequencing instruments, reagents, and...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $66,483.01, is for a Preventive Maintenance and Repair Agreement for an Illumina MiSeq system. The contract has an ultimate completion date of May 16, 2025 and does not utilize any set-aside designations. Illumina has been awarded numerous prime federal contracts and grants...